XORTX Therapeutics (XRTX) Profit After Tax (2020 - 2026)
XORTX Therapeutics (XRTX) posted Profit After Tax of -$808472.0 for Q1 2026, up 82.88% on a QoQ basis from -$4.7 million in Q4 2025, and down 15.72% year-over-year from -$959216.3 in Q1 2025.
XORTX Therapeutics (XRTX) Profit After Tax (2020 - 2026) Analysis & Trends
XORTX Therapeutics' Profit After Tax history runs 7 years deep, the most recent figure standing at -$808472.0 for Q1 2026.
- Quarterly Profit After Tax fell 15.72% year-over-year to -$808472.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.1 million (down 225.5% YoY) and the FY2025 annual result came in at -$2.7 million, down 180.17% from the prior year.
- Profit After Tax was -$808472.0 for Q1 2026 at XORTX Therapeutics, up from -$4.7 million in the prior quarter.
- Across five years, Profit After Tax topped out at $7.0 million in Q4 2023 and bottomed at -$4.7 million in Q4 2025.
- A 5-year average of -$564004.6 and a median of -$1.2 million in 2022 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2023 — Profit After Tax jumped 426.32% — and 2025, when it slumped 623.29%.
- XORTX Therapeutics' Profit After Tax stood at -$2.1 million in 2022, then soared by 426.32% to $7.0 million in 2023, then fell by 3.79% to $6.7 million in 2024, then sank by 169.97% to -$4.7 million in 2025, then surged by 82.88% to -$808472.0 in 2026.
- Business Quant data shows XRTX's Profit After Tax at -$808472.0 in Q1 2026, -$4.7 million in Q4 2025, and -$649469.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | XORTX Therapeutics | 20.40 Mn | 20.40 Mn | - | -808,472.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -808,472.00 |
| Dec 31, 2025 | -4.72 Mn |
| Sep 30, 2025 | -649,469.00 |
| Jun 30, 2025 | -889,945.00 |
| Mar 31, 2025 | -698,673.00 |
| Dec 31, 2024 | 6.75 Mn |
| Sep 30, 2024 | -587,011.00 |
| Jun 30, 2024 | 170,066.00 |
| Mar 31, 2024 | -3.02 Mn |
| Dec 31, 2023 | 7.02 Mn |
| Sep 30, 2023 | -1.33 Mn |
| Jun 30, 2023 | -1.69 Mn |
| Mar 31, 2023 | -1.83 Mn |
| Dec 31, 2022 | -2.15 Mn |
| Sep 30, 2022 | -1.20 Mn |
| Jun 30, 2022 | -1.24 Mn |
| Mar 31, 2022 | -2.70 Mn |
| Dec 31, 2021 | 7.21 Mn |
| Sep 30, 2021 | -6.64 Mn |
| Jun 30, 2021 | -218,446.00 |